{"nctId":"NCT00674661","briefTitle":"Corneal Collagen Cross-Linking for Ectasia (CXL)","startDateStruct":{"date":"2007-12"},"conditions":["Ectasia"],"count":130,"armGroups":[{"label":"Corneal Collagen Cross-linking (CXL) Treatment Group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: riboflavin ophthalmic solution","Device: UVA Irradiation"]},{"label":"Control Group","type":"SHAM_COMPARATOR","interventionNames":["Drug: riboflavin ophthalmic solution"]}],"interventions":[{"name":"riboflavin ophthalmic solution","otherNames":[]},{"name":"UVA Irradiation","otherNames":["UV-X™ Illumination System"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of ectasia after refractive surgery\n* Documented ectasia on Pentacam or topography map\n* BSCVA worse than 20/20\n* Must complete all study visits\n\nExclusion Criteria:\n\n* History of delayed wound healing\n* History of corneal melt or corneal dystrophy","healthyVolunteers":false,"sex":"ALL","minimumAge":"14 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline in Maximum Keratometry (Kmax)","description":"The primary efficacy parameter was corneal curvature, as measured by maximum keratometry (Kmax) in the study eyes. Study success was defined as a difference of ≥1 D in the mean change in Kmax from baseline to 12 months between the CXL group and control group. Keratometry was measured manually and by pentacam.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"2.2"},{"groupId":"OG001","value":"0.5","spread":"2.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":67},"commonTop":["Corneal opacity","Eye pain","Corneal epithelium defect","Punctate keratitis","Vision blurred"]}}}